The other major risk is the type of product
[10] U.S
Learn More in eNeuro | Society for Neuroscience Rethinking Alzheimers: Harnessing Cannabidiol to Modulate IDO and cGAS Pathways for Neuroinflammation Control - Sahar Emami Naeini, Bidhan Bhandari, Breanna Hill, Nayeli Perez-Morales, Hannah Rogers, Hesam Khodadadi, Nancy Young, Lvia Maria Maciel, Jack Yu, David Hess, John Morgan, Evila Salles, Lei Wang, and Babak Baban Augusta University The Dental College of Georgia at Augusta University Medical College of Georgia at Augusta University Georgia Institute of Cannabis Research, Medicinal Cannabis of Georgia LLC
We then split the dataset into training and test datasets, T train and T test
In the mITT population, the average change in the number of SSEs from baseline to the end of the study was +0.7 events per month in the pooled groups receiving 1.25 and 1.75 mg doses of BMT, compared to only +0.2 events in the placebo group